Aleva Neurotherapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 14

  • Investments
  • 1

Aleva Neurotherapeutics General Information

Description

Manufacturer of proprietary neurostimulation devices intended to offer therapies for neurological diseases. The company's devices are used as implantable devices for deep brain stimulation (DBS) therapy based on mems technology, thereby enabling researchers to research curing brain stimulation relating to Parkinson's disease and essential tremors.

Contact Information

Website
www.aleva-neuro.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • EPFL Innovation Park
  • Building D
  • 1015 Lausanne
  • Switzerland
+41 021
Primary Industry
Therapeutic Devices
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • EPFL Innovation Park
  • Building D
  • 1015 Lausanne
  • Switzerland
+41 021

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aleva Neurotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aleva Neurotherapeutics‘s full profile, request access.

Request a free trial

Aleva Neurotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of proprietary neurostimulation devices intended to offer therapies for neurological diseases. The company'
Therapeutic Devices
Lausanne, Switzerland
21 As of 2023

Charlotte, NC
 

Minnetonka, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aleva Neurotherapeutics Competitors (5)

One of Aleva Neurotherapeutics’s 5 competitors is Sonablate, a Private Equity-Backed company based in Charlotte, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sonablate Private Equity-Backed Charlotte, NC
Monteris Medical Venture Capital-Backed Minnetonka, MN
Medtronic Corporation Minneapolis, MN
HistoSonics Venture Capital-Backed Plymouth, MN
ClearPoint Neuro Formerly VC-backed Solana Beach, CA
You’re viewing 5 of 5 competitors. Get the full list »

Aleva Neurotherapeutics Patents

  • 57

    Total Documents Applications and Grants

  • Total Patents Families

  • 49

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Aleva Neurotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200376276-A1 Neurostimulation device with recording patch Active 28-May-2019
US-11344728-B2 Neurostimulation device with recording patch Active 28-May-2019
US-20220266024-A1 Neurostimulation device with recording patch Pending 28-May-2019
EP-3812002-A1 Neurostimulation device with recording patch Pending 28-May-2019
EP-3784340-A1 Clinical neurostimulation controller Inactive 25-Apr-2018 A61N1/37247
To view Aleva Neurotherapeutics’s complete patent history, request access »

Aleva Neurotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aleva Neurotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aleva Neurotherapeutics‘s full profile, request access.

Request a free trial

Aleva Neurotherapeutics Investments (1)

Aleva Neurotherapeutics’s most recent deal was a Joint Venture with Adept Neuro. The deal was made on 25-Jun-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Adept Neuro 25-Jun-2019 Joint Venture Other Devices and Supplies
To view Aleva Neurotherapeutics’s complete investments history, request access »

Aleva Neurotherapeutics FAQs

  • When was Aleva Neurotherapeutics founded?

    Aleva Neurotherapeutics was founded in 2008.

  • Where is Aleva Neurotherapeutics headquartered?

    Aleva Neurotherapeutics is headquartered in Lausanne, Switzerland.

  • What is the size of Aleva Neurotherapeutics?

    Aleva Neurotherapeutics has 21 total employees.

  • What industry is Aleva Neurotherapeutics in?

    Aleva Neurotherapeutics’s primary industry is Therapeutic Devices.

  • Is Aleva Neurotherapeutics a private or public company?

    Aleva Neurotherapeutics is a Private company.

  • What is Aleva Neurotherapeutics’s current revenue?

    The current revenue for Aleva Neurotherapeutics is .

  • How much funding has Aleva Neurotherapeutics raised over time?

    Aleva Neurotherapeutics has raised $65.6M.

  • Who are Aleva Neurotherapeutics’s investors?

    Kiri Capital, Efung Capital, Initiative Capital Romandie, LifeLink Ventures, and Forrestal Capital are 5 of 16 investors who have invested in Aleva Neurotherapeutics.

  • Who are Aleva Neurotherapeutics’s competitors?

    Sonablate, Monteris Medical, Medtronic, HistoSonics, and ClearPoint Neuro are competitors of Aleva Neurotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »